drugset / Trial / NCT05095259

Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes

NCT05095259

Non-randomizedParallel-groupOpen-labelBasic science

Summary

An experimental mechanistic study. The overall objective is to gain new knowledge about mechanisms involved in adaptation to recurrent hypoglycaemia in diabetes by investigating patients with type 1 diabetes and healthy controls. The knowledge to be obtained may feed into experimental hypoglycaemic clamp studies to further elucidate the effect of the adaptations during acute hypoglycaemia. Ultimately, it may lead to intervention studies aiming at the maintenance of functional capability during hypoglycaemia in patients with type 1 diabetes to reduce their risk of severe hypoglycaemia.

Timeline

Start
2019-12-16
Primary completion
2023-12
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified 10 ng
Subject Epinephrine Other / unclassified 25 ng
Subject Epinephrine Other / unclassified 50 ng
Subject Glucagon Peptide 10 ug Intravenous
Subject Glucagon Peptide 25 ug Intravenous
Subject Glucagon Peptide 50 ug Intravenous
Subject Insulin Protein / enzyme biologic 7 iu Intravenous